Objective: The purpose of this study was to evaluate the effect of lobectomy on pulmonary function in patients with chronic obstructive pulmonary disease.
Results:
In patients with preoperative FEV 1 greater than 80% of predicted, postoperative FEV 1 /FVC slightly but not significantly decreased, and postoperative FEV 1 significantly decreased. In patients with preoperative FEV 1 less than 65%, postoperative FEV 1 and FEV 1 /FVC significantly increased. In patients with preoperative FEV 1 /FVC greater than 70%, postoperative FEV 1 and FEV 1 /FVC significantly decreased. In patients with preoperative FEV 1 /FVC less than 70%, postoperative FEV 1 /FVC increased, and FEV 1 remained unchanged. In patients with a chronic obstructive pulmonary disease index greater than 1.5, postoperative FEV 1 and FEV 1 /FVC significantly decreased, whereas in patients with a chronic obstructive pulmonary disease index less than 1.5, postoperative FEV 1 /FVC significantly increased and FEV 1 remained unchanged. In patients with residual volume and functional residual capacity greater than 115% and transfer factor of the lung for carbon monoxide less than 80% of predicted, postoperative FEV 1 diminished less (not significant) compared with patients who had residual volume and functional residual capacity less than 115% (P ϭ .0001). Observed postoperative/predicted postoperative FEV 1 was higher if FEV 1 /FVC was less than 55% (1.46), if FEV 1 was less than 80% of predicted (1.21), or if the chronic obstructive pulmonary disease index was less than 1.5 (1.17).
Conclusions:
Patients with mild to severe chronic obstructive pulmonary disease could have a better late preservation of pulmonary function after lobectomy than healthy patients. L ung cancer remains an important cause of death among smokers, and this condition is often associated with chronic obstructive pulmonary disease (COPD). Surgical resection offers the best chance for curing lung cancer, and lobectomy is the most frequent operation performed. Postoperative respiratory failure is a widely known complication that limits parenchymal resection in patients with COPD; exclusion criteria have been adopted to evaluate these patients, and [2] [3] [4] [5] [6] [7] Unfortunately, most of these reports on lobectomy in patients with airway obstruction reviewed a limited number of cases, and the selection of operable patients remains a great challenge. [2] [3] [4] [5] [6] [7] The goal of this study was to evaluate the effect of lobectomy on pulmonary function in COPD patients.
Materials and Methods
This was a retrospective, multicenter national study. Data from 7 Italian hospitals with thoracic surgery experience (including lung transplantation, lung volume reduction surgery, or both) were collected. All patients with at least 1 preoperative and 1 postoperative pulmonary function evaluation who underwent lobectomy for lung cancer from March 1997 to March 2003 were considered; usually no more than a 6-month period was analyzed for each center. Postoperative pulmonary function tests (PFTs) were performed not earlier than the third postoperative month and not later than the 15th month. Patients who received any adjuvant or neoadjuvant therapy were not considered eligible for this study. One hundred thirty-seven patients met the criteria (35 women and 102 men); 49 had normal static and dynamic pulmonary function, according to European Respiratory Society 1993, whereas 88 had COPD ranging from grade 1 to 3 according to Global Initiative on Obstructive Lung Disease guidelines. Hyperinflation was considered if residual volume (RV) and functional residual capacity (FRC) were greater than 115% of predicted and vital capacity was in the normal limit, and impairment of gas transfer was defined as TLCO less than 80% of predicted. PFTs were performed in different laboratories by using the European Respiratory Society 1993 predicting values. All tests were performed with the same methods, and static volumes were measured by the nitrogen washout method. Patients were evaluated by radiograph and computed tomographic scan to stage the tumor, to ascertain the presence of a flattening diaphragm, and to distinguish bullous from nonbullous emphysema.
Ninety-two patients underwent upper lobectomy, 37 underwent lower lobectomy, and 8 underwent middle lobectomy; 17% of these patients had bullous emphysema, and 32% had diaphragmatic flattening. Thirty-one had squamous cell cancer, 72 had adenocarcinoma, 5 had small cell lung cancers, and 4 had carcinoid tumors. In 25 patients, histologic results were not available or were uncertain.
In all patients, the observed postoperative The COPD index was calculated according to Korst and associates 5 to evaluate the severity and purity of obstructive airway disease; the preoperative FEV 1 (percentage of predicted in decimal form; FEV 1 %) was added to the preoperative ratio of FEV 1 to FVC. Patients with the lowest COPD index are those with the most severe airway obstruction. Patients with a COPD index greater than 1.5 do not have obstructive diseases.
The mean age of COPD patients was 68 Ϯ 15 years, and the mean age of non-COPD patients was 66 Ϯ 13 years (mean Ϯ SD). FEV 1 ranged from 980 mL (34% of predicted) to 4050 mL (115% of predicted) in the entire study population. Preoperative functional data in healthy and COPD patients are shown in Table 1 .
Statistical analysis included the paired t test for comparison of preoperative and postoperative mean values, because the patients were observed before and after a single treatment. Smith's statistical software package version 2.5, 2001 (by G. Smith, Claremont, Calif) was used for all analyses. Statistical methods included multiple comparisons of interrelated parameters, and this may cause problems with determining the appropriate significance level. To overcome this problem, we computed the number of comparisons for each category group (each table) priate factor accordingly. In particular, for 4 ϫ 4 comparisons, the significance level was decreased by 20-fold (from .05 to .002), and for 4 ϫ 2 comparisons, the significance level was decreased by 10-fold (from .05 to .005).
Results
Flow volume and blood gas analyses were available in all patients, dynamic and static lung volumes were available in 108 patients, and carbon monoxide diffusion capacity was available in 89 patients. Preoperative chest radiographs and computed tomographic scans were examined in most COPD patients to consider diaphragmatic flattening and bullous emphysema. No postoperative differences were observed with regard to the lobectomy area because upper, lower, or middle lobe resection did not influence the postoperative FEV 1 or FEV 1 /FVC change. Patients were divided into different groups to characterize the grade of airway obstruction, the grade of hyperinflation, and the grade of carbon monoxide diffusion capacity. Changes of functional variables before and after operation were then analyzed. Figure 2 ).
COPD index group 1 included 52 patients with an index greater than 1.5, and COPD index group 2 included 85 patients with an index less than 1.5. In COPD group 1, FEV 1 /FVC and FEV 1 significantly decreased, whereas in COPD group 2, FEV 1 /FVC significantly increased, and FEV 1 remained unchanged (Table 4 ). The observed postoperative/predicted postoperative ratio for FEV 1 in group 2 (1.17 Ϯ SD 0.06) was higher than in group 1 (0.91 Ϯ SD 0.1; Figure 3 ).
Hyperinflation Parameters (RV and FRC)
RV group 1 included 53 patients with RV greater than 115%, and RV group 2 included 55 patients with RV less than 115%. In RV group 1, FEV 1 slightly (P ϭ .06) decreased, and FEV 1 /FVC remained unchanged; in RV group 2, FEV 1 significantly decreased, and FEV 1 /FVC remained unchanged (Table 5) . FRC group 1 included 55 patients with FRC greater than 115%, and FRC group 2 included 53 patients with FRC less than 115%. In FRC group 1, FEV 1 and FEV 1 /FVC remained statistically unchanged, whereas in FRC group 2, FEV 1 decreased, and FEV 1 /FVC remained unchanged (Table 6 ).
Alveolar Diffusion Parameter (TLCO)
TLCO group 1 included 35 patients with a TLCO of 80% or more, and TLCO group 2 included 54 patients with a TLCO less than 80%. In TLCO group 1, FEV 1 significantly decreased, whereas FEV 1 /FVC did not change; in TLCO group 2, FEV 1 decreased, and FEV 1 /FVC increased, but these differences were not significant (Table 7) .
Discussion
Our results suggest that pulmonary function after lobectomy improves-or at least diminishes less-in COPD patients as compared with non-COPD patients and that this phenomenon is more evident in patients with more severe airway obstruction and hyperinflation. In particular, some of the preoperative functional parameters seem to be good predictors of late postoperative function improvement (or minimal change). FEV 1 /FVC improves if preoperative FEV 1 is less than 65% of predicted, if preoperative FEV 1 /FVC is less than 55%, or if the COPD index is less than 1.5, whereas FEV 1 /FVC worsens if the preoperative FEV 1 /FVC is more than 70% and the COPD index is more than 1.5. FEV 1 improves only if the preoperative FEV 1 is less than 65%; it always worsens when airway flow indexes, diffusion capacity, and RV or FRC are in the normal range. Neither obstruction parameters (FEV 1 and FEV 1 /FVC) nor diffusion capacity provides information on postoperative RV changes, because this index always worsens after operation and seems unrelated to these indexes. No change was observed before and after operation regarding oxygen exchange, and these data are unrelated to the preoperative functional data. It is interesting to note that the observed postoperative FEV 1 is better than the predicted postoperative FEV 1 if FEV 1 /FVC is less than 70%, if FEV 1 is less than 80% of predicted, or if the COPD index is less than 1.5. TLCO and RV do not influence these variations. An important and practical consideration is that the predicted postoperative FEV 1 underestimates the observed postoperative FEV 1 by approximately 45% if the preoperative FEV 1 /FVC is less than 55% and by approximately 20% if the preoperative FEV 1 is less than 80% of predicted.
Preoperative evaluation for lung resection in lung carcinoma has been well studied, and many reports have been published to evaluate the early and late operative risk for patients with obstructive airway diseases. [8] [9] [10] [11] Advances in an- 5 reported that the mean change in FEV 1 after lobectomy was ϩ3.7% among patients with a preoperative FEV 1 of less than or equal to 60% of predicted and was Ϫ15.7% for patients with a mean preoperative FEV 1 of 69% of predicted. Sekine and associates 2 documented that the postoperative ventilatory function in COPD patients who had lower or middle/lower lobectomies was better preserved than predicted.
The most important consideration from our study, as well as from other similar studies, [2] [3] [4] [5] is that some patients will have improved obstructive indexes after lobectomy: the increase of FEV 1 /FVC means that airway caliber or elastic recoil improves after resection. Our patients were identified retrospectively; therefore, we cannot know the precise nature of COPD and of the lung tissue resected (apart from the presence of bullae in a small group), but the consistent number of our sample implies that these results are not attributable to lung volume reduction surgery. Nevertheless, we can speculate that the mechanism of this airway improvement could be the relief of hyperinflation and/or chest wall mechanics, although this improvement should not be related to emphysematous lungs. Resection of a dead space in case of local pulmonary artery involvement could be another way to explain functional amelioration in some cases.
This study has several limitations. We analyzed only patients who had been discharged from the hospital, so we did not consider early postoperative mortality or early functional impairment. Furthermore, this was a retrospective study limited to the involvement of 7 different hospitals and selection of patients from different periods. Patients with available postoperative PFTs over a limited period (from the 3rd to 15th postoperative months) and in a consecutive temporal selection were involved. Patients first referred to the respiratory specialist always performed postoperative PFTs, but patients referred to a surgeon usually did not perform postoperative PFTs. Therefore, the selection criteria are related to the specialist who first visited the patient, and this was usually related to the practitioner who addressed the patient for further evaluation of a pulmonary lesion.
In conclusion, patients with mild to severe COPD could present a better late preservation of pulmonary function after lobectomy compared with healthy patients. This minimal deterioration or improvement of airway function seems to be related to preoperative obstructive indexes.
